Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400025 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Stuart Lang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cresset Discovery, New Cambridge House, Bassingbourn Road, Litlington, Cambridgeshire, SG80SSS. Hauptthemen laut MEDLINE: Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Identification and assessment of novel targets is essential to combat drug resistance in the treatment of HIV/AIDS. HIV Capsid (HIV‐CA), the protein playing a major role in both the early and late stages of the viral life cycle, has emerged as an important target. We have applied an NMR fragment screening platform and identified molecules that bind to the N ‐terminal domain (NTD) of HIV‐CA at a site close to the interface with the C ‐terminal domain (CTD). Using X‐ray crystallography, we have been able to obtain crystal structures to identify the binding mode of these compounds. This allowed for rapid progression of the initial, weak binding, fragment starting points to compounds 37 and 38 , which have 19 F‐pK i values of 5.3 and 5.4 respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cresset Discovery, New Cambridge House, Bassingbourn Road, Litlington, Cambridgeshire, SG80SSS.
- BioAscent Discovery Ltd, Bo'Ness Road, Newhouse, Lanarkshire, ML1 5UH.
- Drug Discovery Unit, University of Dundee, Dow Street, Dundee, DD1 5EH.
- Alira Health, Av. De Josep Tarradellas, 123, 7th Floor, 08029, Barcelona, Spain.
- Vertex Pharmaceuticals (Europe) Ltd, 86-88, Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, OX14 4RW.
- Evotec (UK) Ltd, Dorothy Crowfoot Hodgkin Campus, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RZ.
ORCID-Profile: Alain-Pierre Petit, Paul Fyfe, Fabio Zuccotto, Fiona Bellany, Claire J Mackenzie, Paul G Wyatt, David W Gray
Förderung
- Medical Research Council
Zitieren
APA
Lang, S., Fletcher, D. A., Petit, A. P., Luise, N., Fyfe, P., Zuccotto, F., Porter, D., Hope, A., Bellany, F., Kerr, C., Mackenzie, C. J., Wyatt, P. G., & Gray, D. W. (2024). Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments. ChemMedChem. https://doi.org/10.1002/cmdc.202400025
Vancouver
Lang S, Fletcher DA, Petit AP, Luise N, Fyfe P, Zuccotto F, et al. Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments. ChemMedChem. 2024. doi:10.1002/cmdc.202400025
BibTeX
@article{Lang2024,
author = {Lang, Stuart and Fletcher, Daniel A and Petit, Alain-Pierre and Luise, Nicola and Fyfe, Paul and Zuccotto, Fabio and Porter, David and Hope, Anthony and Bellany, Fiona and Kerr, Catrina and Mackenzie, Claire J and Wyatt, Paul G and Gray, David W},
title = {Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400025}
}
EUVIMED